Skip to main content
ON

Onconetix

Cincinnati, United States
Last funding
$12.9M
Post-IPO EquitySep 2026

Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.

Backed byCincyTechSRx Health (formerly Better Choice Company)

About Onconetix

How much funding has Onconetix raised?

Onconetix has raised $12.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2026.

Who are Onconetix's investors?

Onconetix's investors include CincyTech, SRx Health (formerly Better Choice Company).

Where is Onconetix headquartered?

Onconetix is headquartered in Cincinnati, United States.

What does Onconetix do?

Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.

What stage is Onconetix at?

Onconetix is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Onconetix — Funding & Investors." VCBacked, September 24, 2026, https://www.vcbacked.co/company/onconetix. Accessed November 15, 2026.
APA
VCBacked. (2026). Onconetix — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/onconetix
Wikipedia (cite web)
{{cite web |title=Onconetix — Funding & Investors |url=https://www.vcbacked.co/company/onconetix |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Onconetix? Request a listing update

Founder contacts
m***@onconetix.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →